Abstract: Mechanisms controlling the balance between proliferation and self-renewal versus growth suppression and differentiation during normal and leukemic myelopoiesis are not understood. We have used the bi-potent FDB1 myeloid cell line model, which is responsive to myelopoietic cytokines and activated mutants of the granulocyte macrophage-colony stimulating factor (GM-CSF) receptor, having differential signaling and leukemogenic activity. This model is suited to large-scale gene-profiling, and we have used a factorial timecourse design to generate a substantial and powerful data set. Linear modeling was used to identify gene-expression changes associated with continued proliferation, differentiation, or leukemic receptor signaling. We focused on the changing transcription factor profile, defined a set of novel genes with potential to regulate myeloid growth and differentiation, and demonstrated that the FDB1 cell line model is responsive to forced expression of oncogenes identified in this study. We also identified gene-expression changes associated specifically with the leukemic GM-CSF receptor mutant, V449E. Signaling from this receptor mutant downregulates CCAAT/enhancer-binding protein ␣ (C/EBP␣) target genes and generates changes characteristic of a specific acute myeloid leukemia signature, defined previously by gene-expression profiling and associated with C/EBP␣ mutations. J. Leukoc. Biol. 80: 433-447; 2006.
INTRODUCTION
A detailed understanding of the molecular regulation of myelopoiesis is critical for developing new approaches to hematological therapy and for diagnosis and treatment of myeloid leukemia. A number of hematopoietic growth factors (HGFs), or cytokines, play a key role in regulating the myeloid lineage. Binding of the HGF ligand to their receptors results in activation of intracellular kinase activity and induction of multiple signaling pathways. This, in turn, mediates changes in cell behavior, ultimately through changes in gene expression associated with proliferation, survival, self-renewal, and differentiation. This response is mediated in part by modulation of the action of a number of lineage-specific transcription factors (TFs), which act by regulating key target genes such as cell cycle regulators, HGF receptors, and mature cell proteins that define particular cell types or lineages [1, 2] . In addition, these TFs often autoregulate their own promoters and are able to inhibit alternative genetic programs, thus specifying lineage commitment [3] [4] [5] . In the granulocyte-macrophage (GM) lineage, key TFs are the CCAAT/enhancer-binding protein (C/ EBP) family and the ets family member PU.1 (for a recent review, see Rosmarin et al. [6] ), the ratios of which are critical for cell fate [7] . The nature of the links between myeloid HGFs and the action of TFs involved in the cellular response is still largely unclear. To address this important gap in our understanding of myeloid cell responses, we have been examining how intracellular signals initiated by the myeloid HGFs, GMcolony stimulating factor (CSF), and interleukin (IL)-3 impact on transcriptional programs.
Given the pivotal roles of HGF signaling in regulating hematopoiesis, it is not surprising that aberrant HGF receptor activation or activation of pathways downstream of HGF receptors is associated with leukemia. A key example of this is activation of fms-related tyrosine kinase 3 (FLT3), which represents the most commonly mutated gene in acute myeloid leukemia (AML) and is constitutively activated by acquired mutation (most commonly, internal tandem duplications) in 30 -35% of AML cases [8, 9] . Aberrant HGF signaling in AML cells can also result from constitutive activation of other receptors [10 -12] or signaling molecules [13] [14] [15] . Autocrine production of GM-CSF and IL-3 also occur occasionally in AML [16] and chronic myeloid leukemia [17] and also result in constitutive activation of proliferation and survival pathways. The current model for pathogenesis of AML involves cooperation between these mutations and others, which leads to a block in differentiation or acquisition of self-renewal. This is associated with disruption of the normal transcriptional program, sometimes as a result of lesions involving key myeloid TFs such as C/EBP␣ and PU.1 [1] but commonly through the interference of translocation-derived fusion proteins [18] . There are overlaps between the effects of these two cooperating classes of mutation, as for example, FLT3 activation appears to contribute to a differentiation block in some contexts [19] .
With the advent of new, gene-profiling technologies, it has become possible to investigate the molecular basis of myeloid leukemias using approaches that measure global gene-expression changes. Over recent years, there has been a large mass of data generated with respect to the gene-expression profiles of AML patient samples [20 -23] , sets of genes downstream of leukemogenic TFs [24, 25] and associated with FLT3 mutations [19, 26 -28] . Such profiling needs to be considered together with the gene-expression patterns available for myeloid cell line models undergoing directed differentiation [29 -32] and granulocytic populations at different stages [33] . In many of these analyses, gene-expression changes cannot generally be associated, a priori, with a specific cellular process (e.g., mitogenesis, promoting, or blocking differentiation, survival, self-renewal), as in these systems, many processes are occurring simultaneously. Dissection of gene-expression changes associated with each cellular outcome requires differential activation of these processes in parallel cell systems, such that gene-expression profiles can be monitored simultaneously. With such a system, a linear modeling approach permits identification of different classes of genes based on such a complex set of conditions. With this in mind, we turned to a bipotential cell line model of myeloid differentiation, which displays differential responses to GM-CSF, IL-3, and activated GM-CSF receptor mutants. The FDB1 cell line is strictly growth factordependent for survival; however, cells proliferate continuously in the presence of IL-3 with only a minimal amount of spontaneous differentiation to neutrophils, monocytes, and megakaryocytes. In the presence of GM-CSF, FDB1 cells differentiate synchronously along the neutrophil and monocyte lineages with complete differentiation after 5-7 days [34] . This ability to uncouple mitogenesis and self-renewal from differentiation while still using physiological stimuli allows a dissection of these processes, not readily achieved in primary cells, which undergo simultaneous proliferation and differentiation and eventual growth arrest and cell death. To increase the power of this study, we included two activated mutants of the GM-CSF receptor, which have differential leukemogenic activity. These two mutants, FI⌬ and V449E, are derived from the common signaling subunit (h␤ c ) for GM-CSF, IL-3, and IL-5 (reviewed in Gonda and D'Andrea [35] and D'Andrea and Gonda [36] ) and represent two distinct classes of activated receptor [extracellular (EC); transmembrane (TM). The two mutants display overlapping, biochemical responses compared with the GM-CSF and IL-3 receptor complexes [37] and most likely, represent alternative receptor configurations [35] . In vivo, V449E induces a myeloid leukemia consistent with its ability to support the generation of immature myeloid cell lines in vitro [38] , and the EC mutant FI⌬ induces cytokine-independent formation of CFU-GM [colony-forming units-GM] and erythroid progenitor colonies and leads to a myeloproliferative disease in murine models [38, 39] . It is important that the FDB1 cell line also responds differentially to these activated GM-CSF receptor mutants. V449E induces factor-independent proliferation of FDB1 cells and is able to block GM-CSFinduced differentiation, properties that mimic the ability of this mutant to induce AML in vivo. FI⌬ induces factor-independent GM differentiation, reflective of the signals that give rise to myeloproliferative disorder in vivo [34, 40] . Thus, FDB1 provides a manipulable model with which to study downstream signaling and transcriptional responses from cytokines and activated receptors. Here, we have used this model, timecourse gene-expression profiling, and linear modeling to dissect the molecular mechanisms underlying the differential activities associated with the myeloid growth factors GM-CSF and IL-3 and the activated mutants of the GM-CSF receptor. With a view to understanding the molecular control of myeloid differentiation, we focused our downstream and clustering analysis on identification of candidate regulatory genes encoding TFs and TF-associated products. In addition, we have used comparative analysis between our data and other studies focused on C/EBP␣ and AML to examine further the mechanism of leukemic receptor signaling. Here, we provide evidence for a mechanism of leukemic induction by activated growth factor receptor mutants, which may involve modulation of C/EBP␣ activity.
MATERIALS AND METHODS

Cytokines and antibodies
Recombinant murine (m)IL-3 and GM-CSF were produced from baculovirus vectors supplied by Dr. Andrew Hapel (John Curtin School of Medical Research, Canberra, Australia).
Culture and analysis of FDB1 cells
FDB1 cells were maintained as described previously [34] . Infected pools were maintained as described plus 1 g/mL Puromycin (Sigma Chemical Co., St. Louis, MO). Receptor expression (FI⌬ or V449E) was confirmed by staining with a murine anti-FLAG TM antibody (Sigma Chemical Co.) followed by an anti-mouse fluorescein isothiocyanate-conjugated antibody (Silenus, Chemicon International, Temecula, CA). Cells were analyzed by flow cytometry using an Epics Elite ESP (Coulter Electronics, UK). If necessary, cells were sorted for expression as described previously [41] . For the time courses, cells were washed three times in Iscove's modified Dulbecco's medium and cultured in 500 BM U/mL mIL-3 or mGM-CSF or without growth factor {1 BM unit is the amount that gives 50% maximal colony formation (CFU-GM) using bone marrow cells; see ref. [42] }. To assess differentiation, cells were centrifuged onto slides and stained with May-Grü nwald-Giemsa, and the proportion of differentiated cells was determined microscopically. To assess cell viability, the percentage of cells excluding trypan blue was determined using a hemocytometer.
Experimental design
The experiment is arranged as a factorial design studying cell lines and time. For time-course information, each cell population was sampled at six timepoints (0, 6, 12, 24, 48, and 72 h), and the time zero (T 0 ) point was used as a reference to obtain relative expression levels following IL-3 withdrawal. We also included the parental FDB1 cell line maintained in IL-3 to establish any baseline differences at T 0 as a result of expression of the activated receptors. Matched time comparisons were also performed at all six time-points between the two conditions supporting differentiation (GM-CSF and FI⌬) and between the two cell populations expressing activated receptor mutants (FI⌬ vs. V449E). Two biological replicate samples were used for each cell population, and a dye-swap replicate was performed for each comparison.
Hybridization and data analysis
Total cellular RNA was harvested with Trizol (Invitrogen, Carlsbad, CA) and further purified with the RNeasy RNA purification kit (Qiagen, Valencia, CA). Aliquots of RNA were kept to perform quantitative reverse transcriptasepolymerase chain reaction (QRT-PCR) analysis. cDNA was generated using 50 g total RNA as a template and primed with PolyT(V)N (4.0 g) and random hexamers (1.0 g, Amersham, UK). cDNA was labeled with Cy5 or Cy3 dyes using the Cy-Scribe post-labeling kit (Amersham) as per the instructions. Labeled cDNA was hybridized to microarray slides printed with the CompuGen Mouse OligoLibrary (v2.0, 21,997 65-mers comprising 21,587 unique genes) by the Adelaide Microarray Facility (Australia). Slides were scanned using a GenePix 3000B scanner (Axon Instruments, Sunnydale, CA), and the Spot package (CSIRO, Australia) was used to identify spots and estimate fore-and background intensities (using a morphological opening background estimator) [43, 44] . Data analysis was performed in R (www.r-project.org) using the Limma package of Bioconductor [45, 46] and in-house scripts. Arrays were normalized using intensity-dependent spatial normalization and scale normalization [47] . Spatial loess was also applied to a subset of arrays [48] . Linear modeling and F-test-based classifications were performed with the Limma package of bioconductor [45] . We estimated, effects for baseline (T 0 ) differences between cell lines change over time in FI⌬ (0, 72 h) and sample by time-interaction parameters between FI⌬ and V449E and between FI⌬ and GM-CSF. To examine the distribution of differentially expressed genes for a given comparison of interest, we constructed a volcano plot, in which we plotted log 2 (fold change) on the x-axis and the -log 10 [false discovery rate (FDR)-adjusted P value] on the y-axis. This generates a volcano-like shape, in which genes at low fold changes are typically not differentially expressed (P values close to 1; -log(p) approaching zero), and those with strong evidence for differential expression typically have high fold-change values. Gene ontology (GO) over-representation analysis was performed using GO-STAT using the CompuGen Library as the comparison set and applying a FDR P value adjustment [49] . Promoter analysis was performed using the CUREOS database (http://cureos.wehi.edu.au) using Transfac matrix M00770 (V$CEBP_Q3, www.biobase.de) and requiring mouse and human homology. A 2 test was used to test for over-representation of consensus-binding sites. Additional information may be found under Gene Expression Omnibus (GEO) Accession GSE3333. We have followed the guidelines set out by the Microarray Gene Expression Data Society (www.mged.org/miame).
Clustering of TFs
GO terms were obtained via the SOURCE website (http://source.stanford.edu, UniGene build 139) or via direct query of the National Center for Biotechnology Information gene database. To increase sensitivity further to potential TFs, we used homologene to extracted GO terms for human homologs. We selected all genes, which were children of the terms transcription (GO:0006350), nucleoplasm (GO:0005654), DNA binding (GO:003677), or transcription regulator activity (GO:0030258) or contained the terms "transcription," "histone," or "chromatin" in their GenBank Description. A total of 2338 genes was selected as transcription factor-associated. This was reduced down to 340 after filtering out genes with nonsignificant F-test values (1ϫ10
Ϫ5
). Clustering was performed using the Diana algorithm (R cluster package). We evaluated the distance between two profiles using a measure based on that of Bar-Joseph [50] for comparing two time profiles. Briefly, for a gene i, a smoothed spline curve C was fitted to each of the five time-course and matched time data sets. The distance between two genes (i and j) for time course p was calculated as d ijp ϭ
, and the total distance was then calculated as
The dendrogram was then cut at a height of 1.25 to define 14 clusters. Full annotation information of genes in each cluster is listed in Supplementary Table 1 .
QRT-PCR
Aliquots of RNA prepared for the microarray analysis were subjected to real-time RT-PCR analysis. For this, RNA was treated with DNase (Ambion, Austin, TX), reverse-transcribed with Oligo-dT (Ambion) using Omniscript RT (Qiagen). The sequences of the oligonucleotides used for PCR are listed in Supplementary Table 2 . Gene-specific PCR reactions were performed for 38 cycles using Amplitaq Gold (Perkin Elmer, Wellesley, MA) and recommended conditions. SYBR green (10ϫ; Molecular Probes, Eugene, OR) was added to a final concentration of 0.6ϫ per reaction, which was performed on the Rotor-Gene 3000 and related software used for data collection and to determine mean expression values relative to Cyclophilin A (Corbett Research, Version 5.0). Amplification products were analyzed by melt curve and resolved on 2% agarose to confirm specificity. Analysis was performed using a mixedeffects linear model to estimate T 0 differences between each cell line and mean changes within cell lines over time, treating PCR run as a blocking variable.
Retroviral transduction and functional analysis in the FDB1 cell line
For functional analysis, the full-length c-Myb cDNA was cloned into the murine stem cell virus (MSCV)-internal ribosome entry site (IRES)-green fluorescence protein (GFP) retroviral vector and FDB1 cells infected by cocultivation as described previously [40] . Following infection with virusproducing cells, GFP ϩ FDB1 cells were isolated by flow cytometry and expanded in mIL-3. For testing, cells were withdrawn from IL-3 and monitored for morphological differentiation in the presence and absence of GM-CSF for 5 days, as described previously [40] . Changes in cell morphology were recorded following cytocentrifugation of cells onto a glass slide and staining with May-Grü nwald-Giemsa.
Association of the V449E gene set with leukemia subsets identified by gene profiling
We downloaded the (MAS5) normalized data used by Valk et al. [51] from GEO (GSE1159-21979). The normalized data were loaded into R for analysis with the Limma package, and the patients were divided into the 16 clusters (groups) as defined in ref. [51] . For each cluster, we compared expression in patients against normal controls, and for each gene obtained, FDR adjusted P value. We then mapped the V449E-associated gene set (see Table 4 ) to the probes on the HG-U133A GeneChip. After cross-species mapping, the V449E-associated data set reduced from 44 probes to 30. Then, for each of the 16 clusters identified in this study, we looked for association between our V449E gene set and genes differentially expressed in this cluster. We ranked all genes on the array on the basis of FDR-adjusted P values and then examined the distribution of ranks of the 30 Affymetrix probes homologous to our V449E gene set. Significance was assessed using a Wilcoxon rank sum test as implemented in R.
RESULTS
A model system of myeloid cell growth and differentiation
We have previously outlined the use of retroviral infection to generate FDB1 cell populations expressing the activated GM-CSF receptor mutants FI⌬ and V449E [40] . A similar level of expression of the hßc mutant in each population was confirmed by staining for the FLAG epitope fused to the N terminus of the mutant ␤ subunit (Fig. 1A) . For each condition, changes in morphology, growth, and viability were quantitated (see Fig. 1 , B and C). The FDB1 cells behaved as described previously [34, 40] , and complete differentiation to granulocytes and macrophages (approximately equal ratio) occurred over 5 days in GM-CSF and in response to the FI⌬ signal. The switch from IL-3 to V449E signaling did not result in any discernible change to morphology, growth, or viability of the FDB1 cells.
Experimental design and data generation
For dissection of signaling pathways, we performed a timecourse study using FDB1 cells switched from a continuous growth signal (IL-3) to signaling via the leukemic receptor, V449E, or to conditions permitting synchronous monocytic and granulocytic differentiation (GM-CSF or FI⌬). This allowed a parallel time-course comparison to reveal gene-expression changes associated with the switch to alternative differentiation-inducing signals (GM-CSF or FI⌬) or signaling via the leukemia-inducing V449E mutant. In addition, we performed comparisons between cell populations at matched time-points to reveal differences in gene expression between cells undergoing differentiation or proliferation/self-renewal. The overall experimental design, incorporating matched-time and time- course comparisons (along with dye swaps and biological replicates), is shown schematically in Figure 2 and was based on admissible design criteria [52] . A major strength of this design is that it allows estimation of genes with differential expression in the initial cell populations (i.e., T 0 differences) and time-related changes within a cell population (main effects). It is important that this design also permits identification of genes with significantly different expression profiles between cell populations over time (interaction effects).
Linear modeling to identify differentially expressed genes
The linear modeling approach is particularly well-suited to factorial experiments comparing one parameter (cell population) against another (time) and is more powerful than the alternative approach of analyzing the data set as a series of smaller experiments with the same total number of slides [45] . We used a linear modeling approach that allowed us to combine arrays from different cell populations and use an F-testbased approach to select genes with complex expression profiles of potential biological interest [45, 46] . This allowed us to identify common gene-expression changes between FDB1 cell populations undergoing one or more fates in common as shown in Figure 2 . Thus, we classed differentiation-associated genes as those that increased in expression over 72 h in the FI⌬ and/or the GM-CSF cell population and for which this change was significantly greater than the change (if any) in the V449E cell population. The criteria used to select proliferation and self-renewal-associated genes were identical, except that we required decreases in gene expression rather than increases. Using an F-test with a FDR-adjusted P value cut-off of 1 ϫ 10 Ϫ5 and a minimum change of 1.4-fold, we identified 205 differentiation-associated genes and 175 proliferation or selfrenewal-associated genes. These gene sets are represented in volcano plots in Figure 3 , which provide a visual indication of the relative evidence for differential expression of a given gene. Figure 3A shows a clear increase in the number of genes displaying differential expression over time, based on FDRadjusted P value, in the parental FDB1 population shifted to GM-CSF and the FI⌬ population. Although few significant changes are observed at the 6-h time-point, clear groups of differentiation-associated (red) and proliferation-associated (green) genes are identified by this analysis over the 72-h time-course. To examine V449E signaling as a model of leukemic-activated cytokine receptor signaling, we compared the gene-expression profiles of the parental FDB1 cells and the FI⌬ population (in IL-3) with the V449E cell population under the same conditions. Using an F-test with a FDR-adjusted P value cut-off of 1 ϫ 10 Ϫ5 and a minimum change of 1.4-fold, we identified 44 genes specifically down-regulated by the V449E mutant (shown in purple in Fig. 3B ). It is interesting that this gene set is strongly differentiation-associated, as indicated by the increased expression of these genes over time in the parental cells responding to GM-CSF and in the FI⌬ population (Fig. 3A) . This is most likely reflective of the ability of V449E to block differentiation of myeloid cells, a property that is crucial for induction of AML in vivo.
After examining profiles of genes with significant geneexpression changes under various conditions, we selected 10 genes of interest and performed QRT-PCR to provide validation for the microarray results (Fig. 4) . For each gene, we then made eight comparisons and compared significance level and direction between microarray and QRT-PCR-based estimates. For the 80 comparisons made, we observed 72.5% concordance on significance level and direction. In general, microarray-based estimates of fold changes were smaller than those from QRT-PCR.
Validation of the model system-measuring gene-expression changes and function in the FDB1 system
As discussed above, we identified differentiation-associated genes on the basis of elevated expression in the FI⌬ and/or the GM-CSF population and stable expression in the V449E population. Table 1 lists all 205 differentiation-associated genes together with their fold-changes and FDR P values over 72 h in the FI⌬ cell population (changes in GM-CSF were similar and are supplied along with full gene annotation information in Supplementary Table 3) . Example gene-expression profiles are shown in Figure 5A . GO analysis of this gene set indicated significant over-representation of terms such as defense response (GO: 0006952, Pϭ2ϫ10 Ϫ8 ), response to wounding (GO: 0009611, Pϭ5ϫ10 Ϫ6 ), and chemotaxis (GO: 0006935, Pϭ5ϫ10 Ϫ5 ), consistent with up-regulation of genes involved in mature granulocytes and macrophages. Many of the genes identified in this analysis are known to be associated with myeloid differentiation (Table 2) , thus providing an important validation of this cell-line model of myeloid differentiation and confirming the hypothesis that genes displaying concordant regulation in response to the FI⌬ mutant and GM-CSF will be of most relevance to GM differentiation in vivo.
We also examined genes for which higher levels of expression are associated with proliferation and self-renewal. We identified these on the basis of their maintained expression at 72 h in the V449E-expressing FDB1 population and their differences between each cell population. In each plot, the set of 205 differentiation-associated genes is represented by red points, the 175 proliferation and self-renewal-associated genes by green points, and the 44 genes specifically down-regulated in V449E at 0 h by purple points. The dashed gray line represents a FDR-adjusted P value cut-off of 0.01. We see that in FI⌬ and GM-CSF populations, many of the highlighted genes show early evidence of change, and changes become more significant over time. Typically, the genes down-regulated in V449E at T 0 stay down-regulated at subsequent time-points, and they display increased expression over time in the FI⌬ and GM-CSF FDB1 populations (A). down-regulation in the FI⌬ population or in cells responding to GM-CSF. Table 3 lists the 175 proliferation-associated genes (for full gene annotations, see Supplementary Table 4) . Several of the genes in Table 3 have known ability to block differentiation or have a reported association with an immature hematopoietic cell phenotype (Table 2) . Example gene-expression profiles are presented in Figure 5B . In particular, the protooncogene c-Myb has known roles in regulation of myeloid cell proliferation (for review, see ref. [53] ), and the microarray profile for c-Myb was verified using Northern analysis (see Supplementary Fig. 1 ). As a representative of this class of genes and to test the capacity of the FDB1 cell line to respond to a known myeloid oncogene, we used a retroviral vector to enforce expression of c-Myb in FDB1 cells. Figure 6 shows that FDB1 cells infected with a MSCV-IRES-GFP retroviral vector expressing c-Myb are blocked in differentiation in the presence of GM-CSF. In addition, we have shown that these cells can be maintained in GM-CSF long-term, consistent with overexpression of c-Myb generating a complete block in myeloid differentiation. Although this is not unanticipated, given the transforming capacity of Myb [54] , nevertheless, it highlights the ability of our expression analysis to identify genes that function as hematopoietic regulators and the ability of such genes to perturb growth and differentiation in the FDB1 model system. We conclude from this analysis that the FDB1 model displays appropriate gene regulation for myeloid differentiation and that genes identified by this approach are therefore highly likely to have a role in these processes in vivo. The functional testing with c-Myb demonstrates that this cell line will be an extremely useful model of myeloid growth and differentiation, facilitating further analysis of genes identified in this study.
GO and divisive clustering to identify novel candidate myeloid transcriptional regulators
We next used this comprehensive data set to perform a level of gene prioritization aiming to highlight key genes with potential regulatory function. This process greatly facilitates the future functional analysis required to establish cause and effect for any genes of interest. With a view to identification of key myeloid regulators, we used GO terms to identify 340 TFs and TF-associated proteins displaying differential regulation consistent with a potential regulatory role (see Materials and Methods for details). Proteins in these categories can influence cell fate and the switch between proliferation and differentiation [55] and are often involved in leukemic translocations resulting in fusion proteins that have the capacity to reprogram myeloid cell behavior [1] . As TFs with regulatory roles in hematopoiesis often have well-defined patterns of expression, we used divisive, hierarchical clustering on gene-expression profiles under all conditions to group together genes that display coordinate regulation. The clustering approach identified eight clusters (237 genes) associated with proliferation (downregulated during differentiation) and six clusters (103 genes) associated with differentiation (see Supplementary Table 1 for full gene annotation information). Within these divisions, clusters grouped together genes that had a similar rate or magnitude of gene-expression change. A heat map showing all clusters is presented in Figure 7 . To select genes of particular interest from this group, we focused on genes that clustered with genes known to have roles in myelopoiesis or leukemogenesis. This information was taken together with evidence available from the literature (Entrez PubMed, iHOP [56] ) to generate a group of genes with a high probability of having regulatory capacity in the myeloid lineage. These genes are discussed briefly below. Relevant references are summarized in Supplementary Table 5 .
DISCUSSION
Novel regulators of myeloid proliferation and self-renewal
The proliferation-associated cluster (#6) contains the protooncogene c-Myb, discussed above, and a number of other genes involved in the pathogenesis of leukemia through translocations and/or overexpression, including Runx1 [57] , Scl [58] , Calreticulin [59] , Gata2 [60] , and ETO2 [61] , which is highly related to ETO, the founding member of the ETO gene family, and is a partner of AML1/Runx1 in the common t(8;21) translocation in AML. ETO2 itself has also been found to form a translocation fusion product with AML1 in therapy-induced t(16;21) myeloid leukemias; it may affect transcription of several target genes via interaction with the corepressor N-CoR. It is also a target of retroviral insertion in multiple hematopoietic tumors. A recent report describing ETO2 down-regulation during myeloid differentiation agrees with our finding (see Fig. 4 ) [62] . The Ikaros family of TFs was also of particular interest; Eos is present in Cluster 6, and Helios is the sole member of Cluster 8. Helios is known to share some of the functions of Ikaros, with which it can dimerize, but unlike Ikaros, its roles in different hematopoietic lineages are largely undefined [63] . Interrogation of the retroviral-tagged cancer gene database [64] (http://rtcgd.ncifcrf.gov/), using the transcriptional regulators in Cluster 6, revealed Sox4 as a novel gene of interest, as it is the target of 63 retroviral insertions in a range of hematopoietic tumors, including myeloid tumors. A role for Sox4 in myeloid leukemogenesis has been confirmed recently by retroviralmediated, forced expression analysis in an animal model [65] . Cluster 6 also contained the Emx2 homeobox gene, which has been shown to induce alterations in cell fate or changes in behavior of neural cells but has no known role in the myeloid lineage [66] . The transcriptional changes for Helios, Sox4, and Emx2 were confirmed by QRT-PCR, and the results can be seen in Figure 4 .
Novel regulators of myeloid differentiation We also studied a number of transcription-associated factors, which display increased levels of expression, concomitant with growth arrest and onset of morphological differentiation. These have the potential to be important initiators of myeloid differentiation. Clusters 9 and 10 were closely related and contained genes with gradual increases in expression over time in cells undergoing GM differentiation in the GM-CSF and FI⌬ conditions. These clusters included genes known to be involved in inducing myeloid differentiation such as PU.1 [4] , Notch1 [67] , Cdkn2a [68, 69] , and Egr2 [70] . As would be predicted for this class of genes, a number of them (e.g., PU.1 and Cdkn2a) can act as myeloid tumor suppressors. Of novel interest to the myeloid system was the circadian rhythm gene, Per2 [71] , which functions as a tumor suppressor. It is important that a recent study identified Per2 as a C/EBP␣ target gene in myeloid cell lines and showed that enforced Per2 expression induced tumor suppressor activity in leukemic cell lines [72] . Other genes of interest in Clusters 9 and 10 are Btg2 [73, 74] and Tcf7l2 [75] . Btg2 is an antiproliferative, p53-dependent transcriptional coregulator, which may also be a target of c-Myb repression in myeloid cells. The increase in Btg2 gene expression was also confirmed by QRT-PCR (Fig. 4) .
Genes in Cluster 12 generally displayed early and large increases in gene expression (especially in FI⌬-induced differentiation). This cluster contained six genes, and of these, Fos [76] , Egr1 [55] , and Hlx1 [77] are known inducers of myeloid differentiation, making the other three genes (Egr3 [78] , Klf5 [79, 80] , and an uncharacterized expressed sequence tag clone) of potential interest. Egr3 has not been reported to be important in the myeloid lineage but has known roles in the T cell lineage. Klf5 has been reported to be a direct target of C/EBP␣ in myeloid cells and is involved in the C/EBP cascade that regulates adipocyte differentiation [80] . The transcriptional regulation of Klf5 was confirmed by QRT-PCR and can be seen in Figure 4 . A key to understanding the role of these potential novel regulators in the switch between myeloid proliferation and differentiation will be functional analysis approaches in the FDB1 cell line as described above, prior to studies in primary cell and in vivo systems.
A common gene-expression signature between the V449E-activated mutant and human AML: involvement of C/EBP␣ Given the selective leukemogenic capacity of the V449E mutant, we wished to identify gene-expression patterns associated specifically with signaling from this activated mutant. As shown in Figure 3B , there are a striking number of geneexpression differences unique to the V449E cell population. In particular, a total of 44 genes was down-regulated 1.4-fold or more (maximum, eightfold) in the V449E population, relative to the FI⌬ and parental populations in IL-3 (F-test P value 1ϫ10 Ϫ5 ). Fold changes for these genes relative to parental FDB1 cells in IL-3 are shown in Table 4 (for full gene annotations, see Supplementary Table 6 ). Closer inspection of the V449E-down-regulated gene list revealed that 10 of the 44 genes are known C/EBP␣ and/or C/EBPε target genes (marked with asterisks in Table 4 ). To investigate this potential link with C/EBP activity further, we examined promoter regions of this gene set using the Cureos TF/promoter database (http:// cureos.wehi.edu.au). A total of 15 genes contained high-quality C/EBP consensus-binding sequences conserved between mouse and human matches (Transfac matrix V$CEBP_Q3). Given that 4706 of the 17,731 unique genes on the array contained consensus sites, this suggests an over-representation of CEBP-binding sites ( 2 test P value of 0.25). To investigate this link further, we generated a larger gene set by relaxing the requirement that genes must be down-regulated by more than 1.4-fold compared with the parental and FI⌬ population in IL-3 (but retaining the F-test, P value of 1ϫ10 Ϫ5 ). Using this gene set, we observed that 80 of the 203 down-regulated genes contained consensus-binding sites, which represents a significant enhancement ( 2 test P value of 3ϫ10 Ϫ5 ). This suggests that the V449E down-regulated group of genes may contain many novel C/EBP targets in addition to those known targets already identified, and it suggests a model in which V449E signaling affects C/EBP activity, which contributes to a block in differentiation of FDB1 cells [34] and contributing to AML in vivo.
To test whether this V449E-specific gene signature was related to the changes observed in primary human leukemias, we compared the V449E gene set (Table 4 ) with a number of AML signatures identified using gene-expression profiling [51] . For this, we based our analysis on the gene set-enrichment approach of Mootha et al. [87] but adapted the approach for across the microarray platform use by using the Wilcoxon Rank Sum tests. This analysis revealed a highly significant association (Pϭ0.0006) with a specific AML cluster (Cluster 4 in Valk et al. [51] ; Table 5 ). Eight of the 15 leukemias in this cluster carried mutations in the C/EBP␣ gene, suggesting that a loss of C/EBP␣ activity is central to this leukemic phenotype. Taken together, these findings provide further support for a model in which V449E signaling affects C/EBP activity, which is important for is leukemic properties. The FDB1 cell line model provides a system with manipulability, which can now be used to study the mechanism of dysregulation of C/EBP␣ by activated receptor signaling and the target genes that may be central to AML pathogenesis.
In summary, the combination of the FDB1 model of myeloid differentiation and sophisticated array design and analysis tools has identified several genes of interest with regard to regulation of myeloid growth and differentiation and the changes that are associated with myeloid leukemogeneis. The ability of the FDB1 cell line to switch between continued growth and differentiation makes it an excellent primary, functional screening tool, and we have validated this system for functional studies using forced overexpression of the c-Myb proto-oncogene. By using approaches to compare this data set with a myeloid leukemia gene set, we have been able to generalize findings beyond this system. With a view to linking key signaling events to transcriptional programs, we are also investigating the nature of signaling from these activated receptors and differences in gene activation as a result of secondsite receptor mutations or treatment with signaling pathway inhibitors, which affect selective cellular outcomes [40] . This type of analysis provides an opportunity to further correlate specific genes and clusters with myeloid cell proliferation, survival, differentiation, and leukemic receptor signaling and to determine which regions of the GM-CSF receptor and its associated signaling pathways induce these transcriptional changes. P values less than 0.001 are indicated in bold. Note Cluster 4, which contained patients with mostly normal karyotypes with CEBPA mutations. Genes significantly regulated in V449E were from comparisons of the V449E cell population and the parental FDB1 population in IL-3 (i.e., at 0 h; FDR, P Ͻ 0.05).
